Evolus Inc (EOLS)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1171)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

최신 SEC 제출 서류

EOLS's Discussions on Twitter

EOLS을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
EOLS Evolus Inc	13.13	833.94M	202.09M	-61.69M	-35.64M	-1.08
ZTS Zoetis Inc	160.10	71.40B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.03	47.36B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.15	46.03B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.45	18.86B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.26	13.96B	612.78M	-86.37M	-62.91M	-0.87

Evolus Inc Stock (EOLS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-01-29	업그레이드	Barclays	Equal Weight → Overweight
2022-06-23	개시	Needham	Buy
2022-05-12	업그레이드	Barclays	Underweight → Equal Weight
2022-01-20	업그레이드	Truist	Hold → Buy
2021-05-06	업그레이드	Mizuho	Neutral → Buy
2021-04-08	재확인	H.C. Wainwright	Buy
2021-02-24	다운그레이드	Truist	Buy → Hold
2020-07-07	다운그레이드	Mizuho	Buy → Neutral
2020-02-06	재개	Mizuho	Buy
2019-11-26	개시	SVB Leerink	Outperform
2019-09-05	재개	Mizuho	Buy
2019-06-28	개시	Wells Fargo	Market Perform
2019-06-11	개시	Barclays	Underweight
2019-03-20	개시	SunTrust	Buy
2019-02-14	개시	H.C. Wainwright	Buy
2019-01-29	개시	Stifel	Buy

Evolus Inc 주식(EOLS)의 최신 뉴스

Evolus Inc (EOLS) 재무 분석

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

EOLS을(를) 다른 주식과 비교

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc 주식(EOLS)의 최신 뉴스

Evolus’s SWOT analysis: fda approval boosts stock as dermal filler market expands By Investing.com - Investing.com South Africa

Evolus’s SWOT analysis: fda approval boosts stock as dermal filler market expands - Investing.com India

Evolus at Barclays Conference: Strategic Growth and New Launch - Investing.com

Evolus at Leerink’s Global Healthcare Conference: Strategic Growth Insights - Investing.com India

Evolus at Leerink’s Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas - The Motley Fool

What is HC Wainwright’s Estimate for Evolus FY2025 Earnings? - Defense World

(EOLS) Investment Analysis - Stock Traders Daily

Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN

Global Jeuveau Market Outlook 2025-2034: Growth Drivers, Share, And Trends - EIN News

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Principal Financial Group Inc. - Defense World

Evolus, Inc. to Host Earnings Call - ACCESS Newswire

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Rhumbline Advisers - Defense World

IFP Advisors Inc Has $52,000 Position in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Evolus’s Strong Market Position and Growth Potential Highlighted by Robust Revenues and Strategic Expansions - TipRanks

HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS) - Defense World

Evolus’s Promising Growth and Strategic Positioning Earns a ‘Buy’ Rating from Analyst Douglas Tsao - TipRanks

Evolus, Inc. Earnings Call Highlights Robust Growth and Profitability - TipRanks

Evolus Inc Reports Q4 2024 Revenue of $79 Million, Surpassing Es - GuruFocus.com

Stifel maintains Buy on Evolus stock, sets $25 target By Investing.com - Investing.com UK

H.C. Wainwright maintains Buy rating on Evolus stock at $27 target By Investing.com - Investing.com South Africa

H.C. Wainwright maintains Buy rating on Evolus stock at $27 target - Investing.com

Evolus Celebrates Strong Demand For Jeuveau Wrinkle Treatment - Finimize

Assessing Evolus: Insights From 6 Financial Analysts - Benzinga

Evolus price target raised to $25 from $22 at Barclays - TipRanks

Evolus reports Q4 EPS (11c) vs (21c) last year - TipRanks

Evolus, Inc. (NASDAQ:EOLS) Q4 2024 Earnings Call Transcript - Insider Monkey

Evolus Inc (EOLS) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance

Evolus Inc (EOLS) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... By GuruFocus - Investing.com Canada

Evolus, Inc. Achieves Record Financial Growth in 2024 - TipRanks

Evolus Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Evolus earnings missed by $0.13, revenue topped estimates - Investing.com Canada

EVOLUS Earnings Results: $EOLS Reports Quarterly Earnings - Nasdaq

Evolus Q4 Net Loss Narrows, Revenue Rises; Issues Guidance -March 04, 2025 at 05:42 pm EST - Marketscreener.com

Evolus, Inc. (EOLS) Q4 Earnings and Revenues Lag Estimates - Yahoo Finance

Evolus stock rises as Q4 revenue beats estimates, 2025 outlook strong - Investing.com Australia

Evolus stock rises as Q4 revenue beats estimates, 2025 outlook strong By Investing.com - Investing.com South Africa

Evolus, Inc. SEC 10-K Report - TradingView

Earnings Flash (EOLS) EVOLUS Reports Q4 Revenue $78.9M, vs. FactSet Est of $79M - Marketscreener.com

Evolus posts quarterly profit on strong sales of cosmetic injection -March 04, 2025 at 04:05 pm EST - Marketscreener.com

Evolus posts quarterly profit on strong sales of cosmetic injection - TradingView

Is Evolus, Inc. (EOLS) the Best Small Cap Pharma Stock to Buy Now? - MSN

EVOLUS Earnings Preview: Recent $EOLS Insider Trading, Hedge Fund Activity, and More - Nasdaq

Evolus (EOLS) to Release Earnings on Tuesday - Defense World

Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences - Business Wire

How To Trade (EOLS) - Stock Traders Daily

Evolus Management to Reveal Strategic Insights at Two Major Healthcare Investor Conferences - StockTitan

Rice Hall James & Associates LLC Acquires 43,381 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit - BioSpace

Inside Evolus's Growth Strategy: CEO Takes Center Stage at Elite Beauty Summit - StockTitan

Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025 - BioSpace

Evolus Inc (EOLS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

EOLS과 유사한 종목